The BioVax team recently announced a breakthrough in tuberculosis vaccine development. Early trials show promising results, paving the way for advanced studies in combating TB. Previous Post BioVax Participates in Global Tuberculosis Summit 2024 Next Post Advancing Scientific Collaboration and Innovation for Global Health: Strengthening Partnerships Through Research and Knowledge Exchange
PCR Amplification of rv3875–rv2873 and rv3874–rv2389c Genes for DNA Fragment VerificationJune 22, 2026
Advancing Tuberculosis and Precision Tropical Medicine Research through International Collaboration at the University of LeicesterJune 4, 2026